[{"indications": "Indications\u00a0see under Dose", "name": "SUCRALFATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "1 Gastro-intestinal system", "1.3 Antisecretory drugs and mucosal protectants", "1.3.3 Chelates and complexes"], "cautions": "Cautions\u00a0administration of sucralfate and enteral feeds should be separated by 1 hour; interactions: Appendix 1 (sucralfate)Bezoar formation\u00a0Following reports\r\nof bezoar formation associated with sucralfate, caution is advised in seriously ill patients, especially those\r\nreceiving concomitant enteral feeds or those with predisposing conditions such as delayed gastric\r\nemptying", "side-effects": "Side-effects\u00a0constipation; less frequently diarrhoea, nausea, indigestion, flatulence, gastric discomfort,\r\nback pain, dizziness, headache, drowsiness, bezoar formation (see\r\nabove), dry mouth and rash", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2131.htm", "doses": ["Benign gastric and duodenal ulceration and chronic gastritis, adult and child over\r\n15 years, 2\u00a0g twice daily (on rising and at bedtime) or 1\u00a0g 4 times daily 1 hour before meals and at bedtime, taken for\r\n4\u20136 weeks or in resistant cases up to 12 weeks; max. 8\u00a0g daily", "Prophylaxis of stress ulceration, adult and child over 15 years, 1\u00a0g 6 times\r\ndaily; max. 8\u00a0g daily", "child under 15 years see BNF for Children"], "pregnancy": "Pregnancy\u00a0no evidence of harm; absorption from gastro-intestinal\r\ntract negligible"}]